MDT Medtronic plc

Price (delayed)

$127.75

Market cap

$171.93B

P/E Ratio

44.36

Dividend/share

$2.42

EPS

$2.88

Enterprise value

$194.89B

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around ...

Highlights
Medtronic's quick ratio has soared by 50% YoY and by 8% from the previous quarter
MDT's gross profit is up by 14% year-on-year and by 7% since the previous quarter
The price to earnings (P/E) is 30% higher than the 5-year quarterly average of 34.2 but 4% lower than the last 4 quarters average of 46.2
The net income has contracted by 12% YoY but it has grown by 8% from the previous quarter

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.35B
Market cap
$171.93B
Enterprise value
$194.89B
Valuations
Price to earnings (P/E)
44.36
Price to book (P/B)
3.33
Price to sales (P/S)
5.44
EV/EBIT
38.9
EV/EBITDA
25.26
EV/Sales
6.17
Earnings
Revenue
$31.6B
EBIT
$5.01B
EBITDA
$7.71B
Free cash flow
$5.86B
Per share
EPS
$2.88
Free cash flow per share
$4.35
Book value per share
$38.31
Revenue per share
$23.5
TBVPS
$24.69
Balance sheet
Total assets
$91.8B
Total liabilities
$40.14B
Debt
$25.96B
Equity
$51.49B
Working capital
$14.67B
Liquidity
Debt to equity
0.5
Current ratio
2.89
Quick ratio
2.06
Net debt/EBITDA
2.98
Margins
EBITDA margin
24.4%
Gross margin
66.5%
Net margin
12.3%
Operating margin
14.8%
Efficiency
Return on assets
4.1%
Return on equity
7.6%
Return on invested capital
10.4%
Return on capital employed
6%
Return on sales
15.9%
Dividend
Dividend yield
1.89%
DPS
$2.42
Payout ratio
84%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
2.36%
1 week
1.98%
1 month
-2.96%
1 year
18.82%
YTD
9.06%
QTD
1.91%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$31.6B
Gross profit
$21.02B
Operating income
$4.67B
Net income
$3.88B
Gross margin
66.5%
Net margin
12.3%
MDT's net margin is down by 22% year-on-year but it is up by 2.5% since the previous quarter
The operating income has increased by 17% YoY and by 4.1% QoQ
MDT's gross profit is up by 14% year-on-year and by 7% since the previous quarter
Medtronic's revenue has increased by 13% YoY and by 4.9% from the previous quarter

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
P/E
44.36
P/B
3.33
P/S
5.44
EV/EBIT
38.9
EV/EBITDA
25.26
EV/Sales
6.17
The price to earnings (P/E) is 30% higher than the 5-year quarterly average of 34.2 but 4% lower than the last 4 quarters average of 46.2
The EPS has declined by 12% year-on-year but it rose by 7% since the previous quarter
The stock's price to book (P/B) is 28% more than its 5-year quarterly average of 2.6 and 7% more than its last 4 quarters average of 3.1
The company's equity rose by 2.4% YoY
MDT's P/S is 24% higher than its 5-year quarterly average of 4.4
Medtronic's revenue has increased by 13% YoY and by 4.9% from the previous quarter

Efficiency

How efficient is Medtronic business performance
MDT's return on assets is down by 15% year-on-year but it is up by 8% since the previous quarter
Medtronic's return on equity has decreased by 13% YoY but it has increased by 7% QoQ
The company's return on invested capital rose by 7% YoY
The return on sales rose by 3.2% year-on-year

Dividends

What is MDT's dividend history
DPS
$2.42
Dividend yield
1.89%
Payout ratio
84%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 129% greater than the total liabilities
The company's current ratio has surged by 55% YoY and by 9% QoQ
Medtronic's quick ratio has soared by 50% YoY and by 8% from the previous quarter
MDT's debt is 50% smaller than its equity
Medtronic's debt to equity has decreased by 12% YoY
MDT's debt is down by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.